- Physician's Weekly

Time to Kidney Failure a Tool for Communicating Prognosis

Oct 20, 2023

A study has found that estimating time to kidney failure in advanced CKD can inform clinical decisions and patient counseling on prognosis.

Relieving Digestive Obstruction in Patients With Advanced Gastric Cancer

Oct 19, 2023

A study suggests that continuous gastric artery infusion chemotherapy was effective and safe in relieving digestive obstruction in advanced gastric cancer.

Every Physician Has a Role in Reducing Low-Value Care

Oct 19, 2023

Medicine and healthcare are complex. Often, patients hear from friends or family members regarding...

In MS, Exercise Plus Coaching May Improve Atherosclerosis

Oct 18, 2023

An exercise program for patients with MS that included regular remote coaching improved cardiovascular and respiratory health.

NHE3 Inhibitors for IBS-C: A Primary Care Physician’s Perspective

Oct 17, 2023

Physician’s Weekly recently spoke with Linda Girgis, MD, FAAFP, about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.

VMAT2 Inhibitors May Improve Well-Being in Addition to TD Symptoms

Oct 17, 2023

Patients with tardive dyskinesia being treated with vesicular monoamine transporter 2 inhibitors may see improvement in well-being along with TD symptoms.

Strategies for HCV Elimination: Learning from SF

Oct 17, 2023

End Hep C SF placed the city on track to achieve the 2030 HCV elimination target set by the WHO among men who have sex with men who have ever injected drugs.

Disparities Influence Outcomes in Live Donor Liver Transplants

Oct 16, 2023

Known disparities related to race and sex in deceased donor liver transplantation also appear to influence live donor liver transplantation.

NHE3 Inhibitors for IBS-C: A Study Author’s Perspective

Oct 13, 2023

Physician’s Weekly recently spoke with William D. Chey, MD, FACG, AGAF, FACP, RFF, lead author of the phase 3 T3MPO-2 study—which assessed the efficacy of the NHE3 inhibitor tenapanor in treating patients with irritable bowel syndrome with constipation (IBS-C)—about NHE3 inhibitors and their unique method of action (MOA) in treating patients with IBS-C.

Pre-Op HRQOL Impacts Post-Surgery Outcomes in Pediatric Epilepsy

Oct 13, 2023

For children with drug-resistant epilepsy, older age at seizure onset and higher HRQOL before surgery were associated with better postoperative HRQOL.

COVID, RSV & Flu, Oh My!

Oct 12, 2023

“Cold and flu” season is nearly here; however, language matters, and I would argue that it’s important to change our lexicon to more accurately reflect the true health risks of the season.

Treatment Guidelines for Castleman Disease Applicable in Clinical Practice

Oct 12, 2023

An evaluation of guidelines for idiopathic multicentric Castleman disease supports use of IL-6 agents as first-line treatment.

Hand Osteoarthritis Is Not a Systemic Disease of the Cartilage

Oct 11, 2023

Hand joints without osteoarthritis maintain their joint space when other joints have or develop osteoarthritis.

Frequency of ADHD Medication Errors Jumps Nearly 300% From 2000 to 2021

Oct 9, 2023

Increases in ADHD medication-related errors occurred most often among children aged 6-12 and primarily involved inadvertently taking a medication twice.